Signaling pathways
-
BA8987 VorolanibSummary: Vorolanib (CM082) is an orally active, potent inhibitor. - BA8988 TrapidilSummary: Trapidil is a vasodilator.
- BA8990 AnsornitinibSummary: Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2).
- BA8991 NVP-ACC789Summary: An inhibitor.
- BA8992 CT52923Summary: CT52923 is a selective platelet-derived growth factor receptor antagonist with oral activity.
- BA8993 BMS-605541Summary: BMS-605541 is a selective and orally effective kinase inhibitor.
- BA8994 PF-4618433Summary: PF-4618433 is a potent and selective inhibitor.
- BA8995 NCGC00188636Summary: NCGC00188636 is a novel covalent pyruvate kinase inhibitor.
- BA8997 BBT594Summary: BBT594 is a potent receptor tyrosine kinase inhibitor.
- BA8999 WF-47-JS03Summary: WF-47-JS03 is a potent and selective kinase inhibitor, more than 500-fold more selective than for kinase insert domain receptors (KDRs).